BCL2 and hepatocellular carcinoma: The combination of curcumenol and 34 inhibited the proliferation, migration, and invasion of human hepatoma HepG2 cells, as shown by reduced levels of pSTAT3 and BCL-2, dose-dependently decreased hydrogen sulfide (H2S) synthetase, and downregulated VEGF and its downstream key genes pAkt and pERK1/2 [237].